ALTAMIRA THERAPEUTICS LTD (CYTO) Earnings History & Surprises

NASDAQ:CYTO • BMG0360L1349

Current stock price

0.3 USD
-0.11 (-25.94%)
At close:
0.262 USD
-0.04 (-12.67%)
After Hours:

CYTO Earnings overview

Past quarterly earnings results for ALTAMIRA THERAPEUTICS LTD (CYTO), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
N/A

Last Reported

Most Recent
Release Date
Sep 10, 2024
Period
Q2 / 2024
EPS Reported
EPS Surprise
%
Revenue Surprise
%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q2 2024 - - - -
Q4 2023 - - 62.748K - -79.76%
Q2 2023 - - - -100.00%
Q4 2022 - - 310K - 416.67%
Q2 2022 - - 1.22M - -
Q4 2021 - - 60K - -
Q2 2021 -0.50 - - - -
Q4 2020 - - - -
Q2 2020 - - - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

Revenue Historical Q2Q growth and Acceleration

CYTO Revenue Q2Q GrowthCYTO Revenue Q2Q GrowthRevenue Q2Q Growth Q4/22 Q2/23 Q4/23 0 100 200 300 400

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

CYTO Overview CYTO Technical Analysis Report CYTO Fundamental Analysis Report CYTO Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

ALTAMIRA THERAPEUTICS LTD / CYTO Earnings FAQ

What is the most recent earnings date for CYTO stock?

ALTAMIRA THERAPEUTICS LTD (CYTO) last reported earnings on 9/10/2024.

Can you provide information on whether ALTAMIRA THERAPEUTICS LTD beat earnings estimates in the last quarter?

ALTAMIRA THERAPEUTICS LTD (CYTO) missed EPS estimates and missed revenue estimates in the most recent quarter.